1. Home
  2. FGI vs MYNZ Comparison

FGI vs MYNZ Comparison

Compare FGI & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGI
  • MYNZ
  • Stock Information
  • Founded
  • FGI 1987
  • MYNZ 2021
  • Country
  • FGI United States
  • MYNZ Germany
  • Employees
  • FGI N/A
  • MYNZ N/A
  • Industry
  • FGI Industrial Specialties
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • FGI Industrials
  • MYNZ Health Care
  • Exchange
  • FGI Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • FGI 9.5M
  • MYNZ 9.8M
  • IPO Year
  • FGI 2022
  • MYNZ 2021
  • Fundamental
  • Price
  • FGI $1.03
  • MYNZ $0.38
  • Analyst Decision
  • FGI Buy
  • MYNZ Buy
  • Analyst Count
  • FGI 1
  • MYNZ 2
  • Target Price
  • FGI $4.00
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • FGI 8.6K
  • MYNZ 1.4M
  • Earning Date
  • FGI 08-07-2024
  • MYNZ 08-13-2024
  • Dividend Yield
  • FGI N/A
  • MYNZ N/A
  • EPS Growth
  • FGI N/A
  • MYNZ N/A
  • EPS
  • FGI 0.06
  • MYNZ N/A
  • Revenue
  • FGI $120,832,857.00
  • MYNZ $895,479.00
  • Revenue This Year
  • FGI $7.37
  • MYNZ $67.40
  • Revenue Next Year
  • FGI $5.82
  • MYNZ $191.13
  • P/E Ratio
  • FGI $17.17
  • MYNZ N/A
  • Revenue Growth
  • FGI N/A
  • MYNZ 69.00
  • 52 Week Low
  • FGI $0.80
  • MYNZ $0.32
  • 52 Week High
  • FGI $1.90
  • MYNZ $4.79
  • Technical
  • Relative Strength Index (RSI)
  • FGI 57.10
  • MYNZ 42.55
  • Support Level
  • FGI $0.86
  • MYNZ $0.40
  • Resistance Level
  • FGI $1.20
  • MYNZ $0.46
  • Average True Range (ATR)
  • FGI 0.12
  • MYNZ 0.08
  • MACD
  • FGI 0.02
  • MYNZ 0.01
  • Stochastic Oscillator
  • FGI 49.02
  • MYNZ 41.63

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: